Following its debut on the Prague stock exchange in December, Pegas Nonwovens will focus on investment risks including an adjustment to its customer portfolio. According to managing director Milos Bogdan, sales to its largest customer will comprise 40% of total sales this year compared to 57% last year. Additionally, Pegas’ eighth line, scheduled for late 2007, will allow the company to focus more on the medical market. Currently, 89% of Pegas’ output targets the hygiene segment.
On its first trading day on the PSE, Dec. 18, Pegas’ trading volume reached upward of 2.5 billion shares, with a value of Kč 2 billion, and the share price closed up 4.6% at Kč 784, although it had traded as high as Kč 835 during the day. However, Pegas and the entire market began falling mid-week due to end-of-year profit taking and poor trading on foreign markets.